Bedrosian Camille L Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$6.14M

Insider Activity of Bedrosian Camille L

According to the SEC Form 4 filings, Bedrosian Camille L, being in a position of

  1. Chief Medical Officer at Amylyx Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 23069 shares for $513,492,
    over all time since 2024-09-30, has bought 0 shares, and sold 64396 shares for $798,659.

Biography of Bedrosian Camille L

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $513,4923100

Comparison of Insiders on Amount of Buys and Sells

2026-09-10SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
10,028
0.0091%
$32.40$324,868-10.8%
2026-03-02SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
6,461
0.0075%
$14.58$94,205+16.14%
2025-12-01SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
6,580
0.008%
$14.35$94,418+13.38%
2025-09-30SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
12,039
0.0145%
$14.58$175,518+8.39%
2025-03-31SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
12,425
0.0137%
$3.47$43,082+241.24%
2024-12-02SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
5,421
0.0078%
$5.54$30,007-3.78%
2024-09-30SaleAmylyx Pharmaceuticals, Inc.
AMLX
Chief Medical Officer
11,442
0.0096%
$3.20$36,559+54.01%
2023-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
3,881
0.0055%
$45.25$175,615-7.58%
2022-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
2,821
0.004%
$66.62$187,935-29.29%
2022-01-30SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
1,657
0.0024%
$66.30$109,859-29.21%
2021-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
359
0.0005%
$81.14$29,129-17.23%
2021-09-02SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
2,500
0.0036%
$100.18$250,450-30.71%
2021-09-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
2,500
0.0037%
$100.03$250,075-29.04%
2021-05-06SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
364
0.0005%
$113.67$41,376-29.17%
2021-04-15SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
5,000
0.0074%
$109.09$545,450-23.42%
2021-03-01SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
4,543
0.0066%
$138.18$627,752-38.37%
2021-01-30SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
2,243
0.0034%
$140.36$314,827-36.11%
2021-01-15SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
25,000
0.0376%
$139.18$3.48M-31.45%
2020-10-14SaleUltragenyx Pharmaceutical Inc.
RARE
EVP and Chief Medical Officer
262
0.0004%
$88.00$23,056+15.06%
Total: 19
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.